TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 34 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 519 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 519 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 519 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 519 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 519 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 519 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 519 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 519 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 519 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 519 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 519 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 761,201 | $3,380,000 | 0.21% |
| Perceptive Advisors | 522,728 | $2,321,000 | 0.17% |
| THOMPSON DAVIS & CO., INC. | 10,730 | $48,000 | 0.07% |
| Spark Investment Management LLC | 42,200 | $187,000 | 0.02% |
| Vantage Investment Advisors, LLC | 2,273 | $10,000 | 0.01% |
| Virtu KCG Holdings LLC | 50,788 | $225,000 | 0.00% |
| Blume Capital Management, Inc. | 2,546 | $11,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,229 | $19,000 | 0.00% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $8,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 62,343 | $277,000 | 0.00% |